This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Streamline Health® Announces Addition Of Dual Coding Enhancement To Its Collabra™ Software Suite

Streamline Health Solutions, Inc. (NASDAQ: STRM), a leading provider of knowledge management solutions for healthcare providers today announced the release of its dual coding enhancement for the eCAC and eAbstract applications within the Collabra suite of solutions. Streamline Health’s concurrent dual coding solution saves time by allowing coders to assign both ICD-9 and ICD-10 codes to a patient record simultaneously, helping providers prepare for the transition to ICD-10 on Oct. 1, 2014.

According to the American Health Information Management Association (AHIMA), the transition to ICD-10 could cost hospitals from $15 to $20 million each, a large portion of which can be attributed to cash flow disruption related to the changeover. Streamline Health’s concurrent dual coding solution can mitigate revenue loss associated with the transition by allowing provider organizations to become familiar with the new code set ahead of the deadline, and allow them to analyze future reimbursement scenarios.

Concurrent dual coding adds a number of benefits to providers preparing for the switch to the new ICD-10 code set. This solution allows coders to work in both ICD-9 and ICD-10 at the same time, facilitating training on the new codes ahead of the transition and potentially eliminating the need to outsource coding services to a third party. Healthcare organizations are encouraged to implement a dual coding solution as soon as possible to assist in the following areas:

  • Coder Training: Dual coding gives coders the opportunity to practice using ICD-10 and increase familiarity ahead of the Oct. 1, 2014, deadline.
  • Coder Productivity: The concurrent dual coding method will allow providers to measure the potential impact that the transition to ICD-10 will have on coder productivity.
  • Revenue Reimbursement Analysis: Data obtained during this process will provide organizations with the ability to identify potential changes in revenue with specific patient populations and inform them of the need to review or renegotiate payment contracts.
  • Physician Documentation Assessment: Dual coding data can also bring to light potential clinical documentation issues related to ICD-10 and help facilities design more targeted physician training programs.
  • End-To-End Testing: Data produced through concurrent dual coding efforts can help determine an organization’s readiness to process claims using the ICD-10 code set.

“The transition to ICD-10 is just around the corner, and providers are acutely aware that there are many unknowns – especially as they transition from fee for service to a more risk sharing model. By offering concurrent dual coding as part of our computer assisted coding and chart abstraction solutions, we are helping our clients to enhance training efforts and minimize losses to productivity and revenue,” says Robert E. Watson, President and Chief Executive Officer of Streamline Health. “We understand the importance of a well-defined preparation strategy, and we believe that dual coding should be an important component of that strategy.”

1 of 2

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,079.57 -42.44 -0.25%
S&P 500 1,996.74 -3.38 -0.17%
NASDAQ 4,557.6950 -11.9260 -0.26%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs